drugset / Trial / NCT01306292

Safety of SonoVue on Pulmonary Hemodynamics

NCT01306292

Phase 2 Completed 36 enrolled Bracco Diagnostics, Inc
RandomizedCrossoverTriple-blind

Summary

This is an intra-subject crossover comparative safety study to evaluate the effect of intravenous (IV) bolus injection of SonoVue on pulmonary hemodynamics.

Timeline

Start
2011-04
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lumason Diagnostic / imaging agent 4.8 ml Intravenous